Hyperspectral fluorescence imaging for cellular iron mapping in the in vitro model of Parkinson's disease

J Biomed Opt. 2014 May;19(5):051207. doi: 10.1117/1.JBO.19.5.051207.

Abstract

Parkinson's disease (PD) is characterized by progressive dopaminergic cell loss in the substantia nigra (SN) and elevated iron levels demonstrated by autopsy. Direct visualization of iron with live imaging techniques has not yet been successful. The aim of this study is to visualize and quantify the distribution of cellular iron using an intrinsic iron hyperspectral fluorescence signal. The 1-methyl-4-phenylpyridinium (MPP+)-induced cellular model of PD was established in SHSY5Y cells exposed to iron with ferric ammonium citrate (FAC, 100 μM). The hyperspectral fluorescence signal of iron was examined using a high-resolution dark-field optical microscope system with signal absorption for the visible/near infrared spectral range. The 6-h group showed heavy cellular iron deposition compared with the 1-h group. The cellular iron was dispersed in a small particulate form, whereas the extracellular iron was aggregated. In addition, iron particles were found to be concentrated on the cell membrane/edge of shrunken cells. The iron accumulation readily occurred in MPP+-induced cells, which is consistent with previous studies demonstrating elevated iron levels in the SN. This direct iron imaging could be applied to analyze the physiological role of iron, and its application might be expanded to various neurological disorders involving metals, such as copper, manganese, or zinc.

MeSH terms

  • Cell Line, Tumor
  • Cell Membrane / chemistry
  • Cell Membrane / metabolism*
  • Cell Shape / drug effects
  • Ferric Compounds / pharmacokinetics
  • Ferric Compounds / pharmacology
  • Humans
  • Intracellular Space / chemistry
  • Intracellular Space / metabolism*
  • Iron / analysis*
  • Iron / chemistry
  • Iron / metabolism*
  • Optical Imaging / methods*
  • Parkinson Disease / metabolism*
  • Quaternary Ammonium Compounds / pharmacokinetics
  • Quaternary Ammonium Compounds / pharmacology

Substances

  • Ferric Compounds
  • Quaternary Ammonium Compounds
  • Iron
  • ferric ammonium citrate